Haloaryl substituted aminopurines for use in treatment

Provided herein are Aminopurine Compounds, compositions comprising an effective amount of an Aminopurine Compound and methods for treating or preventing cancer, a cardiovascular disease, a renal disease, an autoimmune condition, an inflammatory condition, macular degeneration, ischemia-reperfusion i...

Full description

Saved in:
Bibliographic Details
Main Authors AYALA, LETICIA, KOIS, ADAM, NADOLNY, LISA, HUGHES, KEVIN, PLANTEVIN-KRENITSKY, VERONIQUE, MCCARRICK, MEG, SATOH, YOSHITAKA, SAHASRABUDHE, KIRAN, ALBERS, RONALD, SAPIENZA, JOHN, SLOSS, MARIAN, SUDBECK, ELISE, HENDERSON, IAN, HILGRAF, ROBERT, DELGADO MEDEROS, MARIA, M, COLE, ANDREW, G, HEGDE, SAYEE, PALANKI, MOORTHY, WRIGHT, JONATHAN, CLAREEN, STEVEN, S
Format Patent
LanguageEnglish
French
German
Published 25.06.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided herein are Aminopurine Compounds, compositions comprising an effective amount of an Aminopurine Compound and methods for treating or preventing cancer, a cardiovascular disease, a renal disease, an autoimmune condition, an inflammatory condition, macular degeneration, ischemia-reperfusion injury, pain and related syndromes, disease-related wasting, an asbestos-related condition, pulmonary hypertension or a condition treatable or preventable by inhibition of the JNK pathway comprising administering an effective amount of an Aminopurine Compound to a patient in need thereof.
Bibliography:Application Number: EP20100182984